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The use of medicinal plants for AIDS-related conditions is common in South Africa. In order to establish 
an antiviral rationale for the use of these plants we screened fractions of the methanol extracts of 
medicinal plants for activity against HIV-1 reverse transcriptase (RT) and integrase (IN). The n-butanol 
fraction obtained from the crude methanol extracts of the roots of Bridelia micrantha (Hochst) Baill. 
(Euphorbiaceae) was observed to be as the most active inhibiting the RNA-dependent-DNA 
polymerization (RDDP) activity of HIV-1 RT with an IC50 of 7.3 g/ml. However, it had no activity on the 
3’-end processing activity of HIV integrase. Bioassay-guided fractionation of the n-butanol fraction 
yielded friedelin and -sistosterol, which did not inhibit the RDDP of RT or 3’-end processing functions 
of IN even at a concentration of 500 M. An uncharacterized fraction obtained in the bioassay-guided 
fractionating process inhibited the RDDP with an IC50 of 9.6 g/ml, but had no inhibition on IN. 
Phytochemical screening indicated the presence of flavonoids and tannins in the uncharacterized 
fraction.  
 





Infection with human immunodeficiency virus continues to 
pose a serious public health challenge worldwide owing 
to the lack of preventive or curative therapeutics. Several 
attempts are being made in the search for better anti-HIV 
agents either through molecular modeling of antagonists 
to viral enzymes and structural proteins or through the 
evaluation of plant-derived molecules to identify possible 
lead anti-HIV compounds. South Africa is one of the 
countries with the heaviest HIV burden, with an estimated 
prevalence of 25% as of 2004 when women presenting 
for their first antenatal clinic visits were considered for 
baseline analysis. Running parallel to the high HIV and 
AIDS prevalence is the frequent use of decoctions from 
medicinal plants as treatment for AIDS and AIDS-related 
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anecdotal evidence of the benefits of plants extracts on 
the well-being of HIV/AIDS patients, more data is 
required on the antiviral properties of medicinal plant 
preparations. We report here the biological activity of 
fractions of the crude methanol extracts of six medicinal 
plants from Venda, Limpopo Province of South Africa for 
anti-HIV properties.  
 
 
MATERIALS AND METHODS 
 
We have previously described the inhibitory properties of the crude 
aqueous and methanol extracts of a selection of medicinal plants 
identified in the HIV/AIDS pharmacopoeia of traditional healers in 
Venda, Limpopo Province, South Africa on HIV-1 reverse 
transcriptase and integrase functions (Bessong et al., 2005). In the 
present report, we screen for inhibitory effects of the acetyl acetate, 
butanol and water fractions obtained from the crude methanol 
extracts of six medicinal plants on the RNA-dependent-DNA 
polymerization of HIV-1 RT, and the 3’-processing function of HIV-1 
integrase (IN). HIV-1 RT is responsible  for  the  conversion  of  viral  






proviral integration, two nucleotides are removed from each of the 
3’-end by integrase to produce new ‘hydroxyl ends’ (CA-3’OH) in a 
reaction called 3’-end processing activity. After entering the 
nucleus, the 5’ ends of processed viral DNA are covalently joined to 
the host DNA leading to integration. Reverse transcription and 
integration are essential for infection to be established. 
The plants and plant parts investigated in the present report 
included the roots of Bridelia micrantha (Euphorbiaceae), 
Combretum molle (Combretaceae), Elaendendron transvaalensis 
(Celastraceae), Mucana coriacea (Fabaceae), Vernonia stipulacea 
(Asteraceae), and leaves of Sutherlandia frutescens (Fabaceae) 
and Ricinus communis (Euphorbiaceae). The procurement and 
preparation of the crude methanol extracts of these plants have 
been reported (Bessong et al., 2005). All the reagents used were of 
analytical grade, unless stated otherwise. The acetyl acetate, 
butanol and water fractions were obtained as follows: About 20 g of 
the methanol extract was dissolved in a methanol: water solution 
(80:20, v/v) followed by the addition of hexane (analytical grade) in 
a Buchner funnel. The hexane fraction which usually contains fatty 
materials was separated from the methanol/water soluble fraction. 
The latter was evaporated at 40˚C to dryness under reduced 
pressure. This residue was resuspended in 50 ml of distilled water. 
To obtain the acetyl acetate fraction, 30 ml of acetyl acetate 
(analytical grade) was added to the suspension, vigorously shaken 
for about 5 min and centrifuged at 5000 rpm for 10 min. This was 
done two more times, and the acetyl acetate soluble fraction was 
aspirated each time, pooled, evaporated to a small volume and 
then lyophilized. To obtain the butanol and water soluble fractions, 
the water soluble fraction plus undissolved matter derived from the 
acetyl acetate acquisition process was resuspended in 30 ml of n-
butanol, vigorously shaken and centrifuged as previously 
mentioned. The water soluble fraction was evaporated at 60˚C to 
dryness, while the butanol soluble fraction was evaporated at 40˚C 
to a small volume and then lyophilized. 
The inhibition of reverse transcription activity was evaluated by 
measuring the incorporation of methyl-3H thymidine triphosphate 
([3H] TTP) by RT using polyadenylic acid-oligodeoxythymidilic acid 
(polyA-dT) as a template-primer in the presence and absence of the 
respective fractions. Details of the methodology have been 
described (Bessong et al., 2004). Assessment of the anti-IN activity 
was measure by evaluating the ability of the test substances to 
block the production of a 19 base pair product from a 21 base pair 
model substrate. The methodology used was as previously reported 
(Parissi et al., 2000; Bessong et al., 2005). The fractions were 
tested at a concentration of 1, 10 and 100 g/ml on RT function and 





Due to the appreciable activity of the n-butanol extract of B. 
micrantha on RT we carried out a bioassay-guided fraction in an 
attempt to isolate an active component. Five grams of the n-butanol 
soluble fraction was subjected to vacuum column chromatography 
making use of silica gel, 60-200 microns (Interchim, France). 
Fractions 1a-7a were obtained using a solvent comprising 
petroleum ether : acetyl acetate in the following volume to volume 
ratios 95:5, 90:10, 80:20, 70:30, 60:40, 50:50, 30:70. Fractions 8a-
11a were obtained with 100% acetyl acetate, 100% distilled 
methanol, methanol : water (60:40), and water, respectively. Three 
hundred ml were used in each elution. All fractions were 
evaporated to a small volume and allowed to cool to obtain 
potential crystallization. Through this way, a white precipitate was 
obtained from fractions 2a and 3b which crystallized out of a yellow 
aqueous phase. The precipitate in fraction 2a (0.21 g) was 
subjected to  flash  chromatography  using  petroleum  ether : 
acetyl   acetate (21:1) as solvent to obtain 26 fractions (1b-26b). 
Tubes   were   left  overnight  for  solvents  to  escape  from  which  




fractions 6b-14b yielded fine needle-like crystals. The crystals were 
combined in trichloromethane and evaporated to dryness and 
labeled as substance X.  
Fraction 4a and 5a gave similar profiles on thin layer 
chromatography (TLC) and were combined (0.33 g) and also 
subjected to flash column chromatography with 5 g of silica gel to 
obtain 26 fractions (1c-26c). According to TLC profiles, making use 
of petroleum ether : acetyl acetate (21:1) as the mobile phase, 
fractions 9c-15c were pooled and evaporated to dryness yielding a 
while precipitate of 0.075 g. The latter was further subjected to flash 
column chromatography using dichloromethane as the solvent with 
4 g of silica gel to yield 23 tubes (1d-23d). Tubes 10-23 were 
combined and evaporated to dryness (0.040 g). This product was 





A precipitate (0.01 g) was obtained from fraction 8a upon the 
addition of chloroform. Due to lack of enough quantities for 
extensive chemical and spectroscopic analysis, qualitative assays 
for alkaloids, flavonoids, tannins and saponins were perform using 
standard methods to provide an indication of the possible 
constituents of this substance. The presence of alkaloids was 
determined by adding a few drops of freshly prepared Dragendorrf’s 
reagent to a suspension of fraction 8a and observed for the 
presence of a precipitate. To test for flavonoids, a yellow coloration 
was sought in a revelation test with AlCl3 after TLC, which 
employed acetyl acetate : formic acid (20:0.1) as the mobile phase. 
Quercetin (Sigma) was used as a positive control. To test for 
tannins two methods were used. Firstly, 10 l of a 0.1% FeCl3 
solution was added to approximately 1mg of the test substance. 
The development of a blue black coloration was indicative of the 
presence of tannins. In the second method, a solution of the test 
substance was added to a suspension of commercial gelatin. The 
formation of a white precipitate was indicative of the presence of 
tannins. Commercial tannin (Sigma) was used a positive control. 
Checking for saponins involved the vigorous shaking of an 
approximately 4 ml suspension of the substance for about 15 s and 
observed for a relatively stable froth formation.  
 
 
RESULTS AND DISCUSSION 
 
The n-butanol fraction of B. micrantha was the most 
active with an IC50 of 7.3 g/ml against the RDDP 
function of HIV-1 RT. In general, the n-butanol fractions 
were more inhibitory. The inhibitory profiles of all the 
fractions tested are presented in Table 1. No inhibition 
was observed with the water soluble fractions (Data not 
shown). The electophoretic band intensity of the 3’-end 
processing product formed in the absence of test 
substance was comparable to the bands formed in the 
presence of each of the extract when the 12% 
polyacrylamide gel electrophoretic profiles were analyzed 
by an NIH image apparatus. This means none of the 
fractions inhibited IN activity at the concentrations tested 
(Data not shown).  1H and 14C nuclear magnetic 
resonance data, MS, UV and infrared spectroscopic data  
revealed that substance X and Y were the known 
phytosterols friedelin and -sistosterol, respectively.  
Upon evaluation, friedelin and -sistosterol did not  inhibit  
 




Table 1. Degree of inhibition of the RNA-dependent-DNA polymerization activity of HIV-1 reverse transcriptase by the acetyl acetate and 
n-butanol fractions of South African medicinal plants.  
 
RDDP activity inhibition 
Acetyl acetate fraction n-butanol fraction 
Plant 
% inhibition at 100 g/ml 
(±sd) 
IC50 (g/ml)b % inhibition at 100 g/ml (±sd) IC50 
(g/ml)b 
B. micrantha (roots) 91±3.2 10.4 98.6±2.1 7.3 
E. transvaalensis (roots) 0.0 183.8 48.6±5.3 53.1 
M. coriacea (roots) 97.3±5.1 11.5 97.7±3.7 12.6 
R. communis (roots) 0.0 196.3 22.2±4.8 160.7 
S. frutescens (leaves) a -68±3.6 410.4 -15±1.1 296.3 
V. stipulacea (roots) 12.1+2.8 330.2 00.0 310.1 
 
The acetyl acetate and n-butanol fractions were obtained from the respective crude methanol extracts. 
aFractions of the leaves of S. frutescens were noted to stimulate RT activity. This property was also observed with the crude methanol extract.  




HIV-1 reverse transcription or the 3’-end processing 
activity even at a concentration of 500 M.  
The uncharacterized fraction (8a) inhibited RT activity 
with an IC50 of 9.6 g/ml but had no activity on IN. 
Phytochemical screening indicated that the presence of 
flavonoids and tannins and negative for alkaloids and 
saponins. Friedelin and phenolic derivatives such as 
gallic and ellagic acids have been isolated from the stem-
bark of B. micrantha, and caffeic acid from the leaves of 
the same plant (Pegel and Rogers, 1968). In addition, 
friedelin and ß-sistosterol (Boonyaratavej et al., 1991) 
have been isolated from the roots of the related species 
B. ferruginea, while Onunkwo et al. (1996) indicated the 
presence of flavonoids. Generally, flavonoids are thought 
to have anti-HIV RT properties (Amzazi et al., 2003), and 
are seen to be of potential therapeutic value (Asres et al., 
2005). 
Many plant species are rich in sterols and sterolines 
which have been credited to have immuno-modulatory 
effects and boost the vitality of AIDS patients (Bouic et 
al., 2001; Bouic, 2002). B. micrantha, investigated herein, 
is generally used among the VhaVendas of South Africa 
to cure diarrhea and stomach discomfort, common 
illnesses in AIDS. Whether -sistosterol and fredelin 
contribute to the well-being of patients and as such give 
the plant a spot in the HIV/AIDS pharmacopoeia of some 
Venda traditional healers remains to be determined. It is 
suggested that the acetyl acetate fraction obtained from 
the n-butanol soluble fraction of the methanol extract of 
the roots of Bridelia micrantha be further investigated for 
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